Supporting Parenting at Home: Empowering Rehabilitation Through Engagement (SPHERE) (SPHERE)

Infants with Neurodevelopmental Disabilities (ND) show emotional, cognitive and socio-interactive dysregulation dramatically impacting on caregiving behavior. Early family-centered rehabilitation interventions are effective in promoting better infant outcomes and in optimizing healthcare systems economic return in the long-term. The Video Feedback intervention (VFI) is effective in promoting sensitive parenting and supporting infants' development. In the light of limited resources of the healthcare systems, technological advance in telemedicine may facilitate the delivery of VFI to a greater number of families of infants with ND. Consistently, the Supporting Parenting at Home: Empowering Rehabilitation through Engagement (SPHERE) project is a randomized controlled trial (RCT) aiming at assessing effectiveness and efficacy of an early family centered VFI parenting support delivered through videoconferencing on dyads with infants with ND.

Study Overview

Detailed Description

Infants with Neurodevelopmental Disabilities (ND) show emotional, cognitive and socio-interactive dysregulation dramatically impacting on caregiving behavior. Parents may report critical emotional burden with heightened risk for chronic levels of distress, depression and anxiety. This constitutes a crucial point considering that parenting represents the first preventive factors for infants' development also in the presence of ND conditions. Thus, it is not surprising that early rehabilitation interventions that focus on the parent-infant dyad have been found to be the most effective in recent meta-analytic study and to be the most rewarding for healthcare systems in terms of economic return in the long-term. Specifically, the VFI constitutes an early family-centered intervention that proved to be effective in promoting sensitive parenting and supporting infants' behavioral and socio-emotional development. The use of VFI intervention has been also documented to be beneficial in dyads of children with neurodevelopmental disability reducing child's disruptive and emotionally negative behaviors; promoting maternal sensitivity, increasing self- efficacy and reducing parenting stress. It should be highlighted that delivering VFI in hospital or home-based context should be highly demanding for the healthcare systems due to high cost and disparities in access to the service for families in remote areas. As such, delivering VFI through telemedicine approaches (e.g., videoconferencing) appears to hold promises of promoting a reduction in inequality of care, greater access to early family-centered support and a more effective and efficient promotion of health outcomes for infants with ND. We still do not know how a VFI support for parents of infants with ND may end up in being effective and efficient in terms of promoting infants' development and parental health. Consistently, the Supporting Parenting at Home: Empowering Rehabilitation through Engagement (SPHERE) project is a randomized controlled trial (RCT) aiming at assessing effectiveness of an early family centered VFI parenting support delivered through videoconferencing on dyads with infants with ND.

The SPHERE RCT will include two arms (see arm description) and three assessment phases: T0, baseline; T1, immediate post-intervention; T2, follow-up (6 months after the intervention). For both arms, standardized assessment sessions will include video-recording of mother-infant interaction and maternal self-report scales (depression [Beck Depression Inventory, BDI; Beck et al., 1961]; anxiety [State-Trait Anxiety Inventory, STAI-Y, Spielberg, 1983] parenting stress, [Parenting Stress Index, PSI; Abidin, 1983] and infants' temperament [Infant Behavior Questionnaire Revised, IBQ-R, Gartstein et al., 2003]).

Study Type

Interventional

Enrollment (Anticipated)

168

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • PV
      • Pavia, PV, Italy, 27100
        • Recruiting
        • Mondino Foundation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 month to 1 year (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • infants' (corrected) age between 1 and 18 months;
  • presence of developmental risk or diagnosis of ND as defined by standardized clinical criteria;
  • parental age greater than 18 years;
  • parental mastery of Italian language;
  • parents living together with the infant.

Exclusion Criteria:

  • Twins;
  • Infant's life-threatening conditions;
  • Maternal full-blown documented psychiatric disorders.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SUPPORTIVE_CARE
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Telemedicine Video Feedback Arm
Mother-child dyads will take part into a 6 video-conference sessions of Video Feedback (vVF). The vVF will be standardized according to previously published RCTs. Specifically, the 6 vVFI sessions will be organized in two subsequent phases: 4 sessions based on sharing the focus on different relational themes, and 2 sessions of interactive integration. In more specific terms, during the first set of 4 sessions the psychologist will review with mothers' segments of the videotapes obtained during the baseline assessment and will focus on four different relational themes: responsiveness, physical stimulation, teaching, and parenting experience. During the interactive integration session, the insights developed from the first 4 videoconferences will be applied to the real-time interaction between the parent and his/her infant under the guidance of the psychologist.
Mother-child dyads will take part into a 6 video-conference sessions of Video Feedback (vVF). The vVF will be standardized according to previously published RCTs. Specifically, the 6 vVFI sessions will be organized in two subsequent phases: 4 sessions based on sharing the focus on different relational themes, and 2 sessions of interactive integration. In more specific terms, during the first set of 4 sessions the psychologist will review with mothers' segments of the videotapes obtained during the baseline assessment and will focus on four different relational themes: responsiveness, physical stimulation, teaching, and parenting experience. During the interactive integration session, the insights developed from the first 4 videoconferences will be applied to the real-time interaction between the parent and his/her infant under the guidance of the psychologist.
ACTIVE_COMPARATOR: Psychoeducational booklet arm
Mothers assigned to condition B will receive an informative booklet addressing the same themes discussed in the experimental intervention (i.e., responsiveness, physical stimulation, teaching, and parenting experience), but not tailored on their own infant or specific parenting challenges.
Mothers of this condition will receive an informative booklet addressing the same themes included in the experimental intervention (responsiveness, physical stimulation, teaching, and parenting experience), but not tailored on their own infant status.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maternal sensitivity
Time Frame: Immediate post-intervention (6 weeks after the intervention started)
The maternal sensitivity will be coded through the Global Rating Scales (Murray, Fiori-Cowley, Hooper, & Cooper, 1996). The score will range from 1 (low) to 5 (high).
Immediate post-intervention (6 weeks after the intervention started)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Infant emotional stress reactivity
Time Frame: Immediate post-intervention (6 weeks after the intervention started)
It will be coded as infant negative emotionality through the infant's emotionality coding system (Brambilla et al., 2020; unpublished manual). The proportion of time in which the infant will be positive, neutral or negative will be obtained (score range for each emotion: 0 to 1).
Immediate post-intervention (6 weeks after the intervention started)
Maternal sensitivity
Time Frame: Follow-up (6 months adfter the intervention ended)
The maternal sensitivity will be coded through the Global Rating Scales (Murray, Fiori-Cowley, Hooper, & Cooper, 1996). The score will range from 1 (low) to 5 (high).
Follow-up (6 months adfter the intervention ended)
Infant emotional stress reactivity
Time Frame: Follow-up (6 months adfter the intervention ended)
It will be coded as infant negative emotionality through the infant's emotionality coding system (Brambilla et al., 2020; unpublished manual). The proportion of time in which the infant will be positive, neutral or negative will be obtained (score range for each emotion: 0 to 1).
Follow-up (6 months adfter the intervention ended)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maternal Stress
Time Frame: Immediate post-intervention (6 weeks after the intervention started)
Measured through the self-report scale Parenting Stress Index (PSI; Abidin, 1983). PSI total score ranges from 36 (low) to 180 (high).
Immediate post-intervention (6 weeks after the intervention started)
Maternal Stress
Time Frame: Follow-up (6 months adfter the intervention ended)
Measured through the self-report scale Parenting Stress Index (PSI; Abidin, 1983). PSI total score ranges from 36 (low) to 180 (high).
Follow-up (6 months adfter the intervention ended)
Maternal depression
Time Frame: Immediate post-intervention (6 weeks after the intervention started)
Measured through the self-report Beck Depression Inventory (BDI; Beck et al, 1988). BDI total score ranges from 0 (low) to 63 (high).
Immediate post-intervention (6 weeks after the intervention started)
Maternal depression
Time Frame: Follow-up (6 months adfter the intervention ended)
Measured through the self-report Beck Depression Inventory (BDI; Beck et al, 1988). BDI total score ranges from 0 (low) to 63 (high).
Follow-up (6 months adfter the intervention ended)
Maternal anxiety
Time Frame: Immediate post-intervention (6 weeks after the intervention started)
Measured through the state subscale of the self-report State-Trait Anxiety Inventory (STAI; Spielberger et al., 1983). The state subscale score ranges from 20 (low) to 80 (high).
Immediate post-intervention (6 weeks after the intervention started)
Maternal anxiety
Time Frame: Follow-up (6 months adfter the intervention ended)
Measured through the state subscale of the self-report State-Trait Anxiety Inventory (STAI; Spielberger et al., 1983). The state subscale score ranges from 20 (low) to 80 (high).
Follow-up (6 months adfter the intervention ended)
Infant temperament regulation
Time Frame: Immediate post-intervention (6 weeks after the intervention started)
Measured through the mother-report Infant Behavior Questionnaire-Revised (Gartstein & Rothbart, 2003). The IBQ-R subscale of interest is the "Orienting/Regulatory Capacity". Its score ranges from 1 (low) to 7 (high).
Immediate post-intervention (6 weeks after the intervention started)
Infant temperament regulation
Time Frame: Follow-up (6 months adfter the intervention ended)
Measured through the mother-report Infant Behavior Questionnaire-Revised (Gartstein & Rothbart, 2003). The IBQ-R subscale of interest is the "Orienting/Regulatory Capacity". Its score ranges from 1 (low) to 7 (high).
Follow-up (6 months adfter the intervention ended)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Serena Grumi, PhD, IRCCS Mondino Foundation, Pavia, Italy
  • Study Chair: Livio Provenzi, PhD, IRCCS Mondino Foundation, Pavia, Italy

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 7, 2021

Primary Completion (ANTICIPATED)

June 30, 2023

Study Completion (ANTICIPATED)

December 31, 2023

Study Registration Dates

First Submitted

November 30, 2020

First Submitted That Met QC Criteria

November 30, 2020

First Posted (ACTUAL)

December 7, 2020

Study Record Updates

Last Update Posted (ACTUAL)

April 6, 2021

Last Update Submitted That Met QC Criteria

April 2, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neurodevelopmental Disorders

Clinical Trials on Telemedicine Video Feedback Intervention

Subscribe